Shares of SelectQuote, Inc. (NYSE:SLQT – Get Free Report) traded up 6% during trading on Thursday . The stock traded as high as $4.11 and last traded at $4.09. 309,010 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 1,197,059 shares. The stock had previously closed at $3.86.
Wall Street Analyst Weigh In
A number of analysts have weighed in on SLQT shares. Royal Bank of Canada reissued a “sector perform” rating and set a $4.00 target price on shares of SelectQuote in a research report on Friday, November 22nd. Craig Hallum initiated coverage on shares of SelectQuote in a research note on Monday, September 30th. They set a “buy” rating and a $4.50 target price for the company.
Read Our Latest Analysis on SLQT
SelectQuote Stock Up 2.0 %
SelectQuote (NYSE:SLQT – Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.08). SelectQuote had a negative net margin of 3.45% and a negative return on equity of 15.00%. The company had revenue of $292.26 million for the quarter, compared to analyst estimates of $275.15 million. During the same quarter in the prior year, the company posted ($0.19) EPS. Equities research analysts anticipate that SelectQuote, Inc. will post -0.2 EPS for the current fiscal year.
Hedge Funds Weigh In On SelectQuote
Large investors have recently modified their holdings of the company. Barclays PLC boosted its stake in SelectQuote by 166.8% during the 3rd quarter. Barclays PLC now owns 198,357 shares of the company’s stock valued at $430,000 after purchasing an additional 124,005 shares during the last quarter. KCM Investment Advisors LLC bought a new stake in SelectQuote during the third quarter worth $608,000. State Street Corp raised its position in SelectQuote by 0.7% in the 3rd quarter. State Street Corp now owns 2,894,067 shares of the company’s stock valued at $6,280,000 after buying an additional 21,413 shares during the last quarter. Geode Capital Management LLC lifted its stake in SelectQuote by 1.4% during the 3rd quarter. Geode Capital Management LLC now owns 3,081,391 shares of the company’s stock valued at $6,688,000 after acquiring an additional 43,197 shares in the last quarter. Finally, Creative Planning boosted its holdings in SelectQuote by 6.6% during the 3rd quarter. Creative Planning now owns 100,019 shares of the company’s stock worth $217,000 after acquiring an additional 6,150 shares during the last quarter. 34.59% of the stock is currently owned by institutional investors.
SelectQuote Company Profile
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Read More
- Five stocks we like better than SelectQuote
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Roth IRA Calculator: Calculate Your Potential Returns
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What is the Dogs of the Dow Strategy? Overview and Examples
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.